We are live on ! Find out more
SSWM

Smith Salley Wealth Management Portfolio holdings

AUM $2.3B
1-Year Est. Return 38.65%
This Fund
S&P 500
This Quarter Est. Return
+0.52%
1 Year Est. Return
+38.65%
3 Year Est. Return
+105.94%
5 Year Est. Return
+133.49%
10 Year Est. Return
+415.99%
AUM
$392M
AUM Growth
+$7.11M
Cap. Flow
+$9.29M
Cap. Flow %
2.37%
Top 10 Hldgs %
23.56%
Holding
181
New
12
Increased
75
Reduced
66
Closed
18

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$5.81M
2
NXPI icon
NXP Semiconductors
NXPI
+$4.81M
3
BKNG icon
Booking.com
BKNG
+$3.34M
4
MRK icon
Merck
MRK
+$3.32M
5
AGN
Allergan plc
AGN
+$2.67M

Sector Composition

Rank Sector Weight
1 Healthcare 17.93%
2 Technology 14.41%
3 Financials 13.01%
4 Industrials 10.8%
5 Consumer Staples 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRGO icon
26
Perrigo
PRGO
$1.49B
$5.1M 1.3%
30,792
+1,349
+5% +$215K
CVS icon
27
CVS Health
CVS
$133B
$5.04M 1.28%
48,789
+2,711
+6% +$274K
SLB icon
28
SLB Ltd
SLB
$75.4B
$5.03M 1.28%
60,250
+31,668
+111% +$2.64M
CTRA
29
DELISTED
Coterra Energy
CTRA
$5.03M 1.28%
170,232
+30,243
+22% +$857K
GVI icon
30
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
$4.83M 1.23%
43,161
-16,750
-28% -$1.87M
ABBV icon
31
AbbVie
ABBV
$431B
$4.81M 1.23%
82,113
+7,346
+10% +$444K
TGT icon
32
Target
TGT
$67.3B
$4.76M 1.21%
58,047
-21,004
-27% -$1.62M
CSX icon
33
CSX Corp
CSX
$94.5B
$4.6M 1.17%
416,934
+37,428
+10% +$430K
JNJ icon
34
Johnson & Johnson
JNJ
$614B
$4.59M 1.17%
45,597
-2,534
-5% -$258K
DVN icon
35
Devon Energy
DVN
$50.8B
$4.57M 1.16%
75,789
+4,267
+6% +$260K
AMNB
36
DELISTED
American National Bankshares Inc
AMNB
$4.38M 1.12%
193,935
-23,108
-11% -$522K
MRK icon
37
Merck
MRK
$316B
$4.18M 1.07%
76,226
+58,679
+334% +$3.32M
BWA icon
38
BorgWarner
BWA
$12.9B
$4.14M 1.06%
77,802
-5,639
-7% -$287K
TT icon
39
Trane Technologies
TT
$104B
$4.07M 1.04%
59,726
+6,132
+11% +$405K
LYB icon
40
LyondellBasell Industries
LYB
$19.7B
$4.01M 1.02%
45,692
+9,249
+25% +$778K
BUD icon
41
AB InBev
BUD
$167B
$3.64M 0.93%
29,880
+938
+3% +$113K
GILD icon
42
Gilead Sciences
GILD
$168B
$3.6M 0.92%
36,729
-4,956
-12% -$503K
BKNG icon
43
Booking.com
BKNG
$151B
$3.48M 0.89%
+74,700
New +$3.34M
CELG
44
DELISTED
Celgene Corp
CELG
$3.37M 0.86%
29,209
-4,966
-15% -$593K
ABT icon
45
Abbott
ABT
$182B
$3.25M 0.83%
70,073
-1,080
-2% -$49.6K
CAT icon
46
Caterpillar
CAT
$404B
$3.05M 0.78%
38,089
+3,307
+10% +$275K
DEO icon
47
Diageo
DEO
$48.8B
$2.99M 0.76%
27,074
+2,262
+9% +$260K
BMY icon
48
Bristol-Myers Squibb
BMY
$135B
$2.95M 0.75%
45,720
-2,928
-6% -$183K
AGN
49
DELISTED
Allergan plc
AGN
$2.79M 0.71%
+9,367
New +$2.67M
PFE icon
50
Pfizer
PFE
$145B
$2.77M 0.71%
83,876
+2,905
+4% +$92.4K

Similar funds

Smith Salley Wealth Management's Q1 2015 Portfolio in Review

As of Q1 2015, Smith Salley Wealth Management held 181 positions worth $392M, up 1.8% from $385M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Smith Salley Wealth Management's Q1 2015 filing shows 12 new, 75 increased, 66 reduced and 18 closed positions. Its largest new stake was NXP Semiconductors: 54,608 shares worth $5.48M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $7.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Smith Salley Wealth Management's largest Q1 2015 buy was NXP Semiconductors: 54,608 shares worth $5.48M.
  • Smith Salley Wealth Management added most to Medtronic in Q1 2015, an estimated $5.81M increase.
  • Smith Salley Wealth Management's biggest Q1 2015 reduction was NOV, cutting an estimated $3.46M.
  • Smith Salley Wealth Management fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $7.5M.
  • Smith Salley Wealth Management's ten largest holdings make up 24% of its $392M portfolio in Q1 2015.
  • Smith Salley Wealth Management opened 12 new positions and closed 18 in Q1 2015.
  • Smith Salley Wealth Management's portfolio value rose 1.8% quarter-over-quarter to $392M.

Based on Smith Salley Wealth Management's 13F filing for Q1 2015, filed 5 May 2015.